CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test
Are you concerned about your drug metabolism and its potential effects on your health? DNA Labs UAE offers the CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test to provide you with valuable insights into your genetic profile.
Test Components and Price
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information
Prior to the CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test, it is recommended to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by Cytochrome P450 deficiency.
About the Test
The CYP1A2 gene plays a crucial role in producing an enzyme called cytochrome P450 1A2, which is responsible for metabolizing various drugs and toxins in the body. A deficiency in this gene can lead to altered drug metabolism, potentially impacting the effectiveness and safety of certain medications.
Our genetic testing method, Next-Generation Sequencing (NGS) Technology, allows for the simultaneous analysis of multiple genes or even the entire genome. This advanced technology rapidly sequences large amounts of DNA, enabling us to identify any genetic variants or mutations in the CYP1A2 gene associated with reduced enzyme activity.
The CYP1A2 deficiency genetic test using NGS can help identify individuals at a higher risk of adverse drug reactions or those who may require adjusted drug dosages based on their genetic profile. This information is invaluable for healthcare providers in selecting appropriate medications and optimizing treatment plans for their patients.
It is important to note that genetic testing results should always be interpreted alongside other clinical information. The presence of a genetic variant does not necessarily mean that an individual will experience adverse drug reactions or altered drug metabolism.
Genetic testing should only be performed and interpreted by qualified healthcare professionals who can provide appropriate counseling and guidance based on the results.
Don’t leave your drug metabolism to chance. Get the CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test at DNA Labs UAE and take control of your health today!
| Test Name | CYP1A2 Gene Cytochrome P450 deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CYP1A2 Gene Cytochrome P450 deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Cytochrome P450 deficiency |
| Test Details |
The CYP1A2 gene is responsible for producing an enzyme called cytochrome P450 1A2, which is involved in the metabolism of various drugs and toxins in the body. A deficiency in this gene can result in altered drug metabolism and potentially affect the efficacy and safety of certain medications. Next-generation sequencing (NGS) is a genetic testing method that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses high-throughput sequencing technology to rapidly sequence large amounts of DNA. In the context of CYP1A2 gene deficiency, NGS can be used to identify any genetic variants or mutations in the CYP1A2 gene that may be associated with reduced enzyme activity. NGS genetic testing for CYP1A2 deficiency can help identify individuals who may be at increased risk of adverse drug reactions or may require adjusted drug dosages based on their genetic profile. This information can be useful for healthcare providers in selecting appropriate medications and optimizing treatment plans for patients. It is important to note that genetic testing results should always be interpreted in conjunction with other clinical information, and the presence of a genetic variant does not necessarily mean that a person will experience adverse drug reactions or altered drug metabolism. Genetic testing should be performed and interpreted by qualified healthcare professionals who can provide appropriate counseling and guidance based on the results. |
